» Articles » PMID: 38094651

Apomorphine at the End-of-Life-A Role to Play

Overview
Publisher Wiley
Specialty Neurology
Date 2023 Dec 14
PMID 38094651
Authors
Affiliations
Soon will be listed here.
References
1.
Lokk J, Delbari A . Clinical aspects of palliative care in advanced Parkinson's disease. BMC Palliat Care. 2012; 11:20. PMC: 3528486. DOI: 10.1186/1472-684X-11-20. View

2.
Castillo-Torres S, Lees A, Merello M . Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience. Mov Disord Clin Pract. 2023; 10(2):190-208. PMC: 9941929. DOI: 10.1002/mdc3.13593. View

3.
Oliver D, Veronese S . Specialist palliative care for Parkinson's disease. Ann Palliat Med. 2020; 9(Suppl 1):S52-S62. DOI: 10.21037/apm.2019.12.01. View

4.
Dewhurst F, Lee M, Wood B . The pragmatic use of apomorphine at the end of life. Palliat Med. 2009; 23(8):777-9. DOI: 10.1177/0269216309106979. View

5.
Hvisdak V, Huang A, Kluger B . Palliative Care of End Stage Parkinsonism: An Overview Including the Five Pillars Framework. Mov Disord Clin Pract. 2023; 10(Suppl 2):S63-S67. PMC: 10448122. DOI: 10.1002/mdc3.13620. View